Seeking Alpha

EDAP tanks as Ad Comm meeting approaches

  • Shares of EDAP TMS S.A. (EDAP -21.5%) drop on a 3x surge in volume. Earlier today, the FDA released its briefing documents for Wednesday's meeting of the Gastroenterology and Urology Devices Panel. The Committee will discuss the company's PMA for  the use of Ablatherm HIFU as a treatment for prostate cancer.
  • Investors appear to lack confidence in a positive vote. The agency's comments in the documents imply that reviewers have numerous questions/issues that need to be resolved regarding its clinical trial data.
Comments (1)
  • Dr. Know
    , contributor
    Comments (12) | Send Message
     
    Yikes; any idea's on how to manage this loss before Wednesday's meeting?
    28 Jul, 04:45 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector